Neo Medical Buys TriOs Medical; Appoints New U.S. President

Neo Medical, a Swiss-based firm developing value-based care solutions for functional fusion in spinal surgery, revealed details of U.S. and German expansion plans to support the company’s rapid growth.
 
First, Neo Medical acquired TriOs Medical in Germany. The firm will leverage years of collaboration with TriOs as the company’s exclusive German commercial organization to strengthen its position in the German thoraco-lumbar fixation market. Since the first product launch in Germany in 2017, NEO technologies have been adopted by over 100 German centers and used in over 10,000 surgeries, with more than 90 percent of surgeries performed by recurrent users.
 
Neo Medical also appointed Jon P. Verbiest as president of the company’s U.S. operations. Jon worked for 18 years at Synthes Spine and Depuy Synthes before joining K2M, Spine Wave, Silony Medical, and H Wave in Director of Sales and Business Development roles in the U.S.
 
Neo Medical also deployed a new U.S.-focused organizational structure, appointing new Area Directors to support the company’s continued growth.
 
Speaking about these milestones, Vincent Lefauconnier, Neo Medical CEO, told the press “With a 45 percent growth in 2020, Neo Medical remains on its rapid development trajectory despite the current health and economic context. This year will continue to see the company accelerating in our two strategic markets, Germany and the U.S., starting with the milestones announced today, while growing rapidly in the other European regions where we currently operate. I welcome the TriOs Medical team to our group. The fact that we are joining forces today is a testament to our excellent track record in Germany those past years and I look forward to continuing our success story together with the same management team within Neo Medical. I also welcome Jon P. Verbiest as president for our operations in the U.S., a strategic market for Neo Medical, where we expect to continue our fast growth journey.”